Product Name: CrkL (248-254) pY251
Product Number: PE-04AEQ95
Size: 200 µg      Price:47.00
1 mg      $US94.00
5 mg      206.00
Peptide Name: CrkL (248-254) pY251

Product Use: Services as a blocking peptide for use with the CrkL-pY251 rabbit polyclonal antibody (Cat. No.: AB-PN507) that is also available from Kinexus. This phosphopeptide may also be useful as a substrate for screening the phosphatase activity of protein phosphatases. The peptide sequence is located in the SH3_2 domain. The second major in vivo phosphoryation site in CrkL. The effect of its phosphorylation is unclear.

Peptide Production Method: Solid-phase peptide synthesis

Peptide Origin: Homo sapiens

Peptide Sequence: PCA-pY-DKT

Peptide Modifications N Terminus: Free amino

Peptide Modifications C Terminus: βAla-Cys

Peptide Modifications Other: Phosphorylated

Peptide Molecular Mass Calculated: 1050.08 Da

Peptide Purity Percent after Synthesis and Purification: 95

Peptide Appearance: White powder

Peptide Form: Solid

Storage Conditions: -20°C

Related Product 1: CrkL - pY251 phosphosite-specific antibody (Cat. No.: AB-PN507)

Scientific Background: CrkL is an adapter protein and phosphotyrosine-containing substrate implicated in transformation by Abl and in signalling by cytokines. When phosphorylated, Crkl binds through its Src homology 2 (SH2) domain to other tyrosine phosphoproteins such as paxillin and Cbl.